UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 321

Sortiert nach

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

The New England journal of medicine, 2018-10, Vol.379 (14), p.1313-1321

2018

Volltextzugriff (PDF)

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

The New England journal of medicine, 2012-03, Vol.366 (13), p.1190-1199

2012

Volltextzugriff (PDF)

Novel Volumetric Sub-region Segmentation in Brain Tumors

Frontiers in computational neuroscience, 2020-01, Vol.14, p.3-3

2020

Volltextzugriff (PDF)

Volumetric brain tumour detection from MRI using visual saliency

PloS one, 2017-11, Vol.12 (11), p.e0187209-e0187209

2017

Volltextzugriff (PDF)

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Journal of allergy and clinical immunology, 2012-07, Vol.130 (1), p.145-154.e9

2012

Volltextzugriff (PDF)

Iris Segmentation Using Interactive Deep Learning

IEEE access, 2020, Vol.8, p.219322-219330

2020

Volltextzugriff (PDF)

A Novel GBM Saliency Detection Model Using Multi-Channel MRI

PloS one, 2016-01, Vol.11 (1), p.e0146388-e0146388

2016

Volltextzugriff (PDF)

Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo‐controlled, global phase 3 trial

Journal of dermatology, 2023-05, Vol.50 (5), p.588-595

2023

Volltextzugriff (PDF)

Streamlining neuroradiology workflow with AI for improved cerebrovascular structure monitoring

Scientific reports, 2024-04, Vol.14 (1), p.9245-9245, Article 9245

2024

Volltextzugriff (PDF)

Reproducibility and Explainability of Deep Learning in Mammography: A Systematic Review of Literature

The Indian journal of radiology & imaging, 2024-07, Vol.34 (3), p.469-487

2024

Volltextzugriff (PDF)

Ultra-high resolution, multi-scale, context-aware approach for detection of small cancers on mammography

Scientific reports, 2022-07, Vol.12 (1), p.11622-11622, Article 11622

2022

Volltextzugriff (PDF)

Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept

Arthritis research & therapy, 2022-02, Vol.24 (1), p.47-47, Article 47

2022

Volltextzugriff (PDF)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

Rheumatology international, 2020-07, Vol.40 (7), p.1021-1028

2020

Volltextzugriff (PDF)

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Arthritis research & therapy, 2018-12, Vol.20 (1), p.269-269, Article 269

2018

Volltextzugriff (PDF)

Artificial Intelligence–assisted chest X-ray assessment scheme for COVID-19

European radiology, 2021-08, Vol.31 (8), p.6039-6048

2021

Volltextzugriff (PDF)

Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics

Biomedicines, 2018-05, Vol.6 (2), p.51

2018

Volltextzugriff (PDF)

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

The Journal of dermatological treatment, 2024-12, Vol.35 (1), p.2371045

2024

Volltextzugriff (PDF)

Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression

PloS one, 2016-03, Vol.11 (3), p.e0151014-e0151014

2016

Volltextzugriff (PDF)

Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells

The Journal of nutritional biochemistry, 2009-10, Vol.20 (10), p.816-822

2009

Volltextzugriff (PDF)

Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice

Nutrition research (New York, N.Y.), 2012-12, Vol.32 (12), p.985-990

2012

Volltextzugriff (PDF)

Regulation of expression of citrate synthase by the retinoic acid receptor-related orphan receptor α (RORα)

PloS one, 2012-04, Vol.7 (4), p.e33804-e33804

2012

Volltextzugriff (PDF)

P163 Efficacy of deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor, in musculoskeletal manifestations of systemic lupus erythematosus: a subanalysis of the phase 2 PAISLEY study

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A165-A167

2024

Volltextzugriff (PDF)

P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A168-A169

2024

Volltextzugriff (PDF)

O32 Impact of patient baseline characteristics on SLE Responder Index-4 (SRI[4]) responses to deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor in the phase 2 PAISLEY trial in systemic lupus erythematosus

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A30-A31

2024

Volltextzugriff (PDF)

Generic Cuts: An Efficient Algorithm for Optimal Inference in Higher Order MRF-MAP

Computer Vision – ECCV 2012, p.17-30

Volltextzugriff (PDF)

1 – 25 von 321

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(251)
Mit Volltextzugriff
(289)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(185)
Life Sciences & Biomedicine
(108)
Technology
(67)
Computer Science
(64)
Humans
(57)
Animals
(44)
Computer Science, Artificial Intelligence
(34)
Engineering
(34)
Mice
(33)
Engineering, Electrical & Electronic
(31)
Adult
(25)
Female
(25)
Male
(24)
Biological And Medical Sciences
(22)
Treatment Outcome
(22)
Psoriasis
(20)
Rheumatology
(19)
Patients
(18)
Pharmacology & Pharmacy
(18)
Medical Sciences
(17)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

Novel Volumetric Sub-region Segmentation in Brain Tumors

Volumetric brain tumour detection from MRI using visual saliency

IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis

Iris Segmentation Using Interactive Deep Learning

A Novel GBM Saliency Detection Model Using Multi-Channel MRI

Efficacy and safety of the selective TYK2 inhibitor, deucravacitinib, in Japanese patients with moderate to severe plaque psoriasis: Subgroup analysis of a randomized, double‐blind, placebo‐controlled, global phase 3 trial

Streamlining neuroradiology workflow with AI for improved cerebrovascular structure monitoring

Reproducibility and Explainability of Deep Learning in Mammography: A Systematic Review of Literature

Ultra-high resolution, multi-scale, context-aware approach for detection of small cancers on mammography

Prediction of flare following remission and treatment withdrawal in early rheumatoid arthritis: post hoc analysis of a phase IIIb trial with abatacept

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis

Improved patient-reported outcomes in patients with psoriatic arthritis treated with abatacept: results from a phase 3 trial

Artificial Intelligence–assisted chest X-ray assessment scheme for COVID-19

Cell-Penetrating Peptides to Enhance Delivery of Oligonucleotide-Based Therapeutics

Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials

Pharmacological and Genetic Modulation of REV-ERB Activity and Expression Affects Orexigenic Gene Expression

Green and black tea extracts inhibit HMG-CoA reductase and activate AMP kinase to decrease cholesterol synthesis in hepatoma cells

Phosphorylation of hepatic AMP-activated protein kinase and liver kinase B1 is increased after a single oral dose of green tea extract to mice

Regulation of expression of citrate synthase by the retinoic acid receptor-related orphan receptor α (RORα)

P163 Efficacy of deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor, in musculoskeletal manifestations of systemic lupus erythematosus: a subanalysis of the phase 2 PAISLEY study

P165 Kinetics of mucocutaneous and musculoskeletal responses to deucravacitinib in patients with systemic lupus erythematosus (SLE) in the phase 2 PAISLEY trial

O32 Impact of patient baseline characteristics on SLE Responder Index-4 (SRI[4]) responses to deucravacitinib, a first-in-class, oral, selective, allosteric tyrosine kinase 2 inhibitor in the phase 2 PAISLEY trial in systemic lupus erythematosus

Generic Cuts: An Efficient Algorithm for Optimal Inference in Higher Order MRF-MAP

Suchergebnisse filtern